medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 04

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (04)

Pulmonary hypertension and Eisenmenger syndrome during pregnancy. A case series

Hernández-Cruz RG, Copado-Mendoza DY, Acevedo-Gallegos S, Rubalcava-Rubalcava T, Pérez-Montaño A, Márquez-González H

Language: Spanish
References: 28
Page: 309-317
PDF size: 194.22 Kb.


ABSTRACT

Objective: To describe the evolution and perinatal outcomes of a case series of patients with a diagnosis of pulmonary hypertension and complication with Eisenmenger syndrome.
Materials and Methods: Retrospective, descriptive, cross-sectional study of consecutive case series of patients with a diagnosis of pulmonary hypertension or Eisenmenger's syndrome attended comprehensively from admission to the end of pregnancy at the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes between the months of January 2015 to January 2019.
Results: The average age of the mothers was 25.79 years (15 to 40 years, SD ± 7.19) and the average weeks of pregnancy on admission to the INPer was 22. 5 of 34 patients were classified as having mild pulmonary hypertension, 9 of 34 as having moderate pulmonary hypertension and 20 of 34 as having severe pulmonary hypertension. 9 of 34 cases had Eisenmenger syndrome.
Conclusions: Pulmonary hypertension and Eisenmenger's syndrome during pregnancy continue to be the factors that cause the most serious complications and maternal and fetal mortality. This makes it necessary to care for these patients with an individualized approach, in the hands of an expert, interdisciplinary team, in highly specialized centers, in order to improve the prognosis for the mother and perinatal outcomes.


REFERENCES

  1. McLaughlin V, Archer S, Badesch D, et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association (AHA). JACC 2009; 53: 1573-619. doi. 10.1016 / j.jacc. 2009 .01.004

  2. Martin S, Edwards A. Pulmonary Hypertension and Pregnancy. Obstetrics & Gynecology. 2019; 13 4 (5): 974-87. 10.1097/AOG.0000000000003549.

  3. Barberà J, Román A, Gómez-Sánchez M, Blanco I, et al. Guía de diagnóstico y tratamiento de la hipertensión pulmonar: resumen de recomendaciones. Archivos de Bronconeumología. 2018; 54 (4): 205-15. https://doi.org/10.1016/j. arbres.2017.11.014.

  4. Simonneau G, Montani D, Celermajer D, Denton C, Gatzoulis M, Krowka M et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal. 2019; 53 (1): 1801913. doi. 10.1183/13993003.01913-2018.

  5. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (12 suppl S): 13-24S. 10.1016/j.jacc.2004.02.029.

  6. Calderón-Colmeneroa J, Sandoval-Zárate J, Beltrán-Gámez M. Hipertensión pulmonar asociada a cardiopatías congénitas y síndrome de Eisenmenger. Arch Cardiol Mex. 2015; 85 (1): 32-49. http://dx.doi.org/10.1016/j.acmx.2014.11.008.

  7. Bassily-Marcus A, Yuan C, Oropello J, Manasia A, et al. Pulmonary Hypertension in Pregnancy: Critical Care Management, Pulmonary Medicine 2012; 2012: 1-9. https:// doi.org/10.1155/2012/709407.

  8. Pieper PG, Hoendermis ES. Pregnancy in women with pulmonary hypertension. Neth Heart J 2011; 19:504-508. https://doi.org/10.1007/s12471-011-0219-9.

  9. Smith J, Mueller J, Daniels C. Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach. Lung 2012; 190:155-160. doi. 10.1007 / s00408-011-9345-9.

  10. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006; 92: 1520-25. http://dx.doi.org/10.1136/hrt.2006.095240.

  11. Jastrow N, Meyer P, Khairy P, Mercier LA, Dore A, Marcotte F, Leduc L. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Cardiol 2011; 151 (2): 209-13. 10.1016/j.ijcard.2010.05.045.

  12. Galié N, Hoeper M, Humbert M, et al. For: The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009; 30: 2493-537. doi. 10.1093/eurheartj/ehp297.

  13. Roos-Hesselink J, Baris L, Johnson M, De Backer J, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of Pregnancy and cardiac disease (ROPAC). European Heart Journal 2019; 40 (47): 3848-55. 10.1093/eurheartj/ ehz136

  14. Regitz-Zagrosek, Roos-Hesselink V, Bauersachs J, et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal 2018; 39 (34): 3165-241. https://doi.org/10.1093/eurheartj/ehy340.

  15. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009; 30: 256-65. https://doi.org/10.1093/eurheartj/ehn597.

  16. Olsson K, Channick R. Pregnancy in pulmonary arterial hypertension. European Respiratory Review 2016; 25 (142): 431-37. doi. 10.1183/16000617.0079-2016.

  17. Simonneau G, Galiè N, Rubin L, et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: S5-S12. doi. 10.1016 / j.jacc.2004.02.037

  18. Meng ML, Landau R, Viktorsdottir O, Banayan J, Grant T, Bateman B, et al. Pulmonary hypertension in pregnancy: a report of 49 cases at four tertiary North American sites. Obstet Gynecol 2017; 129: 511-20.

  19. van Hagen, I. and Roos-Hesselink, J, 2020. Pregnancy in congenital heart disease: risk prediction and counselling. Heart, pp.heartjnl-2019-314702. DOI: 10.1016/j. jacc.2016.05.048

  20. Balci A, Sollie-Szarynska KM, van der Bijl AGL, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 2014; 100: 1373-81. http://dx.doi. org/10.1136/heartjnl-2014-305597

  21. Duvekot J, Peeters L. Maternal Cardiovascular Hemodynamic Adaptation to Pregnancy. Obstetrical & Gynecological Survey. 1994; 49 (Supplement): S1. http://dx.doi. org/10.1136/heartjnl-2014-305597.

  22. Ouzounian J, Elkayam U. Physiologic Changes During Normal Pregnancy and Delivery. Cardiology Clinics. 2012; 30 (3): 317-29. https://doi.org/10.1016/j.ccl.2012.05.004.

  23. Elkayam U, Goland S, Pieper PG, Silverside CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol 2016; 68 (3): 396-410. DOI: 10.1016/j.jacc.2016.05.048.

  24. Pieper PG, Balci A, Aarnoudse JG, et al. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation 2013; 128: 2478-87. https://www.ahajournals.org/doi/ full/10.1161/CIRCULATIONAHA.113.002810.

  25. Kiely D, Condliffe R, Webster V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG 2010; 117: 565-74. doi. 10.1111 / j.1471-0528.2009.02492.x.

  26. Avellana P, Segovia J, López F, Gómez-Bueno M, et al. Hipertensión pulmonar y embarazo. Cardiocore 2012; 47 (4): 154-60.

  27. Bedard E, Dimopoulos K, Gatzoulis M. Has there been any progress made on pregnancy outcomes among women with pulmonary artery hypertension. Eur Heart J 2009; 30: 256-65. doi. 10.1093 / eurheartj / ehn597. https://doi. org/10.1093/eurheartj/ehn597

  28. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31: 1650-57. https://www.jacc.org/doi/full/10.1016/S0735- 1097%2898%2900162-4.




2020     |     www.medigraphic.com